<DOC>
	<DOCNO>NCT01135602</DOCNO>
	<brief_summary>12-week , open-label study topiramate hospitalize patient alcoholism</brief_summary>
	<brief_title>Topiramate Hospitalized Patients With Alcoholism : 12-week Study</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Patients hospitalize due alcoholrelated problem DSMIVTR alcohol dependence &gt; /= 35 drinks/week ( male ) &gt; /= 28 drinks/week ( female ) &gt; /= 1 week four week prior admission AUDIT score &gt; /= 8 Mild alcohol withdrawal Body mass index &gt; 18 kg/m2 No pregnancy plan pregnancy ( female ) Intention decrease stop drinking Severe psychiatric cognitive disorder Other substance dependence , except nicotine caffeine dependence , 6 month prior enrollment Taking antipsychotic , mood stabilizer , anticonvulsant , opioid analgesic , systematic steroid , carbonic anhydrase inhibitor , hydrochlorthiazide , metformin , pioglitazone , disulfiram Moderate high risk suicide Medical history narrow angle glaucoma , renal impairment , kidney stone , seizure Unstable medical condition Plan receive formal treatment alcoholism treatment setting Under legal process Pregnancy nursing woman Abnormal laboratory test , include blood urea nitrogen , creatinine , electrolytes , fast blood sugar</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Alcohol dependence</keyword>
	<keyword>Alcoholism</keyword>
	<keyword>Topiramate</keyword>
</DOC>